Background Primary human papillomavirus (HPV) screening was introduced in Australia in
December 2017. Aims Outcomes for women after positive HPV in their cervical screening …

Objectives To report human papillomavirus (HPV) testing patterns and rates of oncogenic
HPV‐positivity for specimens submitted during the first 6 months after the National Cervical …

Aims To assess colposcopic performance and determine indicators for competency within
the new Australian primary human papillomavirus (HPV) cervical screening program …

Objective To review the first two years of the primary human papillomavirus (HPV) cervical
screening programme in an HPV vaccinated population. Design Observational study …

Introduction Primary HPV screening will be implemented into the English Cervical Screening
Programme by 2019. Its impact upon women referred to colposcopy, with negative cytology …

High-risk HPV is found in 99.7% of cervical cancers. The causative role of HPV in cervical
cancer has led to the inclusion of HPV testing as part of cervical screening. A pilot of HPV …

Abstract TRIAGE OF hrHPV-POSITIVE TESTS Most HPV screening programmes that have
transitioned from cytology screening use cytology triage to improve the specificity and …

Furthermore, 90% of women screened were aged over 35 years, when HPV screening is
more clinically effective whereas the English pilot started screening at age 25 years, when …

Aims To examine outcomes in women aged 50–74 years after detection of oncogenic
human papillomavirus (HPV) at cervical screening. Materials and methods A retrospective …

Background Using primary human papillomavirus (HPV) testing for cervical screening
increases detection of high-grade cervical intraepithelial neoplastic lesions and invasive …